Regeneron Pharmaceuticals
REGN
#270
Rank
โ‚ฌ69.41 B
Marketcap
654,94ย โ‚ฌ
Share price
2.57%
Change (1 day)
-3.74%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ67.65 M-22.9%
2024โ‚ฌ87.75 M-26.52%
2023โ‚ฌ0.11 B-5.6%
2022โ‚ฌ0.12 B-53.05%
2021โ‚ฌ0.26 B5.23%
2020โ‚ฌ0.25 B414.86%
2019โ‚ฌ49.73 M-31.98%
2018โ‚ฌ73.11 M69.52%
2017โ‚ฌ43.12 M-78.72%
2016โ‚ฌ0.20 B3.03%
2015โ‚ฌ0.19 B-15.29%
2014โ‚ฌ0.23 B419.89%
2013โ‚ฌ44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
โ‚ฌ21.81 Mโ‚ฌ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ8.65 Mโ‚ฌ41.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ2.15 Mโ‚ฌ78.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ57.52 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ19.76 Mโ‚ฌ75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ9.04 Mโ‚ฌ67.5 M๐Ÿ‡ซ๐Ÿ‡ท France